Infarmed studies co-payment for obesity treatment medications
The Minister of Health states that Infarmed is analysing the potential co-payment for medications used in the treatment of obesity.
Infarmed is analysing potential co-payment for obesity medications
Infarmed is examining the possibility of co-payment for medications to treat obesity, announced the Minister of Health today, following new recommendations on the disease from the WHO this week.
Infarmed evaluates potential co-payment for obesity medications
Infarmed is assessing the possibility of co-payment for obesity treatment medications, announced the Minister of Health on Wednesday, following new recommendations from the WHO regarding the disease. “It must be evaluated by experts and must fall within the guidelines set by the DGS for cases considered severe,” she said ...
